International Patent: SMALL INTERFERING RNAS INHIBITING PROGRAMMED CELL DEATH LIGAND 1 (PD-L1) AND USE THEREOF

GENEVA, July 6 -- LNCTAC CO., LTD. filed a patent application (CN2025/140162) for “SMALL INTERFERING RNAS INHIBITING PROGRAMMED CELL DEATH LIGAND 1 (PD-L1) AND USE THEREOF”. With publication no. WO/2026/138438, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....